
News & announcements
Recent milestones.
Original disclosures.
Corporate, financial and regulatory announcements with their dated source documents.


Q1 FY27: commercial execution and record quarterly results
Read announcement
Masulkhana inspection completed with NIL Form 483
Read announcementPress releases
Latest press releases
Morepen hits record Q2 revenue of Rs. 755 Cr.
Download PDFMorepen enters U.S. prescription generics market, building on its established API strengths
Download PDFMorepen strengthens integrated CDMO capabilities with first U.S. ANDA submission
Download PDFMorepen clocks highest-ever quarterly revenue and earnings in Q1’FY27
Download PDFMorepen starts commercial supplies under its ₹ 825 Crore CDMO mandate
Download PDFMorepen Labs Q4 Net Profit Rises 69%; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10% to the shareholders for FY26
Download PDFMorepen Secures Fourth Consecutive USFDA Inspection with Zero Observations (NIL 483)
Download PDFMorepen Bags ₹825 Crore Global Deal; Expands Into High-Growth CDMO Segment.
Download PDFMorepen Bags ₹825 Crore Global Deal
Download PDFIn the media
News coverage

Presentation at the 41st Annual General Meeting.
Read coverage
Latest Interview with Sushil Suri on ET NOW | Morepen Labs Delivers Its Highest-Ever Q1 Results 💯
Read coverage
Dr. Morepen Partners with VIT Bhopal to Establish Modern Health Centre for 17,000+ Students and Faculty
Read coverageMorepen Laboratories secures ₹825 crore global CDMO Deal
Read coverageInvestor publications
Looking for results
or presentations?
Visit the Investor centre for the supplied releases and access to the official archive.
Investor centreMedia enquiries.
Use the published company contact directory for media enquiries.
